Standard BioTools Inc (LAB) Stock creates opportunities due to its volume and complexity
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (NASDAQ:LAB) Stock Price Settled at $2.68: What’s Resulting?
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
initiated: KeyBanc Capital Markets Recommends Standard BioTools Inc (NASDAQ:LAB) Stock to “an Overweight”
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (NASDAQ:LAB) stock Posted Operating Margin of -60.36 percent in Last Year: Is Admissible?
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (LAB) Stock Still Strong Despite Competition
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Standard BioTools Inc (NASDAQ:LAB) Stock Reported EPS of $0 in Last Quarter
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0. This is […]
Why Standard BioTools Inc (NASDAQ:LAB) Stock went up 22.68% in Last Year?
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Dec 2023) is $0. This is […]
Standard BioTools Inc (NASDAQ:LAB) stock is trading 67.81 percent above its 52-week low
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Dec 2023) is $0. This is […]
In the current cycle, Standard BioTools Inc (LAB) Stock is showing signs of growth
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Dec 2023) is $0. This is […]
Standard BioTools Inc (LAB) Stock is the one stock you should own forever
KeyBanc Capital Markets raised the price target for the Standard BioTools Inc (NASDAQ:LAB) stock to “an Overweight”. The rating was released on July 12, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts It appears that the average earnings per share estimate for the current quarter (ending in Dec 2023) is $0. This is […]